跳至主要内容
临床试验/NCT03646760
NCT03646760已完成不适用

The Improving ATTENDance to Cardiac Rehabilitation Trial

Henry Ford Health System2 个研究点 分布在 1 个国家目标入组 282 人开始时间: 2019年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
282
试验地点
2
主要终点
Number of CR Sessions Completed Within 6 Months in Patients Randomized to HYCR vs. Patients Randomized to Traditional CBCR (Usual Care).

研究概览

简要总结

The benefits of cardiac rehabilitation are well known. However, despite center based cardiac rehabilitation (CBCR) representing guideline-based care for patients with cardiovascular disease, most patients do not complete the maximum number of sessions allowed by third party insurance payers. As such, many patients may not be receiving the full clinical benefit ascribed to CR. This study will assess the efficacy of an innovative approach to CR delivery on attendance by combining both center-based and remote- or home-based CR sessions. The intervention group combines center-based CR and remote-/home-based CR and is tailored to the individual needs of each patient, accomplished with the assistance of an easy-to-access telecommunications methodology (telemedicine)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has agreed to participate in CR and has experienced a cardiac event (myocardial infraction, coronary revascularization, heart valve surgery, or cardiac transplant in the past 6 months; diagnosed with chronic, stable AHA/ACC stage B or C heart failure or Canadian class 0-2 stable angina pectoris)
  • Lives in or plans to remain in the greater Detroit, MI area for the next year
  • Age 18-85 years of age
  • Agrees to attend at least one CBCR session
  • Agrees to scheduling at least 2, up to 3, CR sessions (either CBCR or HYCR)/wk
  • Has demonstrated to research staff their ability to access and connect to the internet via smart phone or tablet and already has access to satisfactory home- or community-based exercise equipment

排除标准

  • Received a left ventricular assist device, receiving continuous inotropic support (e.g., milrinone), or undergoing hemodialysis
  • Angina at rest or with a low functional capacity (< 2 METs)
  • Advanced cancer, advanced risk for falling, limiting cognitive impairment, or other advanced disorder that limits participation in CR
  • Advanced risk for falling will be assessed by 5X sit-to-stand test, with a cut-off score of >15 seconds
  • Cognitive assessment will be completed using the Mini-Cog instrument, with a cut-off score < 3 used to exclude potential subjects.
  • Severe arrhythmia unless adequately treated (e.g., implantable cardiac defibrillator)
  • Pregnant or plan to become pregnant in the next year.
  • Major cardiovascular procedure or hospitalization planned in the next 6 months
  • Less than 12 month life expectancy
  • Participation in another clinical trial that interferes with iATTEND participation, follow-up, data collection, exercise capacity or quality of life.

结局指标

主要结局

Number of CR Sessions Completed Within 6 Months in Patients Randomized to HYCR vs. Patients Randomized to Traditional CBCR (Usual Care).

时间窗: Baseline to 6 months

Percentage of Patients Completing 36 CR Sessions Within 6 Months Among Patients Randomized to the HYCR Program vs. Patients Randomized to the CBCR Program.

时间窗: Baseline to 6 months

Outcome measure is the percent of people who complete all 36 CR sessions and the mean value reported represents the average percentage for all patients in both study groups.

次要结局

  • Improvement in Exercise Capacity, as Measured by Distance Walked During the Six Min Walk (6MW) Test, in Patients Randomized to HYCR vs Patients Randomized to CBCR.(Baseline to 6 months)
  • Improvement in Exercise Capacity, as Measured by Peak Oxygen Uptake (VO2), in Patients Randomized to HYCR vs Patients Randomized to CBCR.(Baseline to 6 months)
  • Improvement in Quality of Life (QOL), as Measured by the Total Score for Dartmouth COOP, in Patients Randomized to HYCR vs Patients Randomized to CBCR.(Baseline to 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven J. Keteyian

Principal Investigator

Henry Ford Health System

研究点 (2)

Loading locations...

相似试验